Company & Sponsor Intelligence
University of Arkansas, Fayetteville
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed2
Countries1
Therapeutic footprint
adhdautism
Indexed studies
NCT06115603The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
adhd · United StatesPHASE2
adhd · United StatesPHASE2
NCT06915415Comparison Between a Live Canine or Toy Dog on Prosocial Behavior and Emotional Regulation in Autistic Children
autism · United StatesNA
autism · United StatesNA
NCT06687850Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →